Liang (Leo) Zhang, MD, PhD

Chief Medical Officer

About

Liang is an executive with over 20 years of experience leading teams in diverse medical and clinical development spaces. Under his leadership as a VP, his company secured multiple investigational new drug (IND) approvals. At his previously held positions at the University of Texas M.D. Anderson Cancer Center, where he played a pivotal managerial role in groundbreaking research and development of innovative oncology therapies.

Country

United States

City

Houston

Industry

Pharmaceuticals

Skill

Growth Strategies, Cross-functional Team Leadership, Regulatory Submissions, Study Reports, Grant Writing, Data Review, Medical Research, Technical Reviews, Strategic Partnerships, Management of Direct Reports, Clinical Strategy, Regulatory Affairs, Interpersonal Skills, Clinical Supervision, Good Clinical Practice (GCP), Oncology, Clinical Development, Clinical Instruction, Teamwork, Patient Derived Xenografts (PDX)

Experience

Chief Medical Officer

Jecho Biopharmaceuticals

2025-11 - Present · 11 mos

Houston, Texas, United States

Vice President

Jecho Biopharmaceuticals

2022-8 - 2025-11 · 3 yrs 4 mos

- Oversaw directors and managers, guiding them in strategic planning and execution to achieve company objectives in terms of clinical development plans, protocols, and financial budgets. Provided strategic direction for product development as the key Advisor on the Science Advisory Board. - Oversaw non-clinical studies, medical affairs, clinical operations, and medical statistics teams to conduct the development of pipeline products - Collaborated with stakeholders and personnel in preclinical and clinical CROs, global strategic marketing, and business development, managing clinical trial project funds with CRO companies

Senior Medical Director

Jecho Biopharmaceuticals

2019-11 - 2022-8 · 2 yrs 10 mos

Tianjin, China

- Directed clinical and medical development, including overseeing clinical development plans, protocols, and financial budgets, and evaluating the benefits and risks in clinical development.